← 返回

乳酸脱氢酶 B 促进肿瘤浸润 CD8(+) T 细胞的二硫死亡和耗竭

英文原题:Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8(+) T cells.

查看英文原题

Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8(+) T cells.

PubMed 2025/06/03(内容时间) Nat Cell Biol Q1 · IF 22.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

细胞内二硫化物的异常积累促进癌细胞二硫死亡;然而,二硫化物应激如何影响肿瘤浸润性CD8+ T细胞功能仍不清楚。在此,我们证明乳酸脱氢酶B(LDHB)促进瘤内CD8+ T细胞二硫死亡和耗竭,导致抗肿瘤免疫受损。CD8+ T细胞通过SLC7A11介导的胱氨酸摄取诱导二硫死亡,这在耗竭CD8+ T细胞的发育中起关键作用。LDHB通过与G6PD相互作用限制耗竭CD8+ T细胞中葡萄糖-6-磷酸脱氢酶(G6PD)活性,导致NADPH耗竭并因此触发二硫死亡。相应地,T细胞中LDHB的缺失可防止二硫死亡依赖性CD8+ T细胞耗竭并改善抗肿瘤免疫。机制上,STAT3指导LDHB表达以限制G6PD活性并介导耗竭CD8+ T细胞中的二硫死亡。我们的结果突出了二硫死亡和铁死亡在驱动CD8+ T细胞耗竭中的不同作用,并提示了一种在癌症免疫治疗中靶向LDHB的潜在治疗策略。

展开英文摘要原文

The aberrant accumulation of intracellular disulfides promotes cancer cell disulfidptosis; however, how disulfide stress influences tumour-infiltrating CD8 + T cell function remains unknown.

Here we demonstrate that lactate dehydrogenase B (LDHB) facilitates intratumoural CD8 + T cell disulfidptosis and exhaustion, leading to impaired antitumour immunity. SLC7A11-mediated cystine uptake by CD8 + T cells induces disulfidptosis, which plays critical roles in the development of exhausted CD8 + T cells.

LDHB restricts glucose-6-phosphate dehydrogenase (G6PD) activity in exhausted CD8 + T cells by interacting with G6PD, causing NADPH depletion and consequently triggering disulfidptosis. Accordingly, the loss of LDHB in T cells prevents disulfidptosis-dependent CD8 + T cell exhaustion and improves antitumour immunity.

Mechanistically, STAT3 directs LDHB expression to limit G6PD activity and mediate disulfidptosis in exhausted CD8 + T cells.

Our results highlight the distinct roles of disulfidptosis and ferroptosis in driving CD8 + T cell exhaustion and suggest a potential therapeutic strategy to target LDHB in cancer immunotherapy.

论文信息

作者
Wan J、Shi JH、Shi M、Huang H、Zhang Z、Li W、Guo C、Bao R
第一作者单位
Hongqiao International Institute of Medicine, Tongren Hospital & Shanghai Institute of Immunology, Department of Immunology and Microbiology, State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China.China
通讯作者单位
Hongqiao International Institute of Medicine, Tongren Hospital & Shanghai Institute of Immunology, Department of Immunology and Microbiology, State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Qzou1984@sjtu.edu.cn.China
期刊
Nature cell biology2025 Jun
原文标识
PubMed 40461882 · DOI 10.1038/s41556-025-01673-2